Related Experiment Videos
Letrozole in the neoadjuvant setting: the P024 trial
1Medical Oncology, Washington University, Campus Box 8056, 660 Euclid Ave, St Louis, MO 63110, USA. mellis@wustl.edu
Breast Cancer Research and Treatment
|November 21, 2007
Summary
Neoadjuvant letrozole, an aromatase inhibitor, shows superior efficacy over tamoxifen for hormone receptor-positive breast cancer in postmenopausal women. It improves response rates and enables more breast-conserving surgeries.
Area of Science:
- Oncology
- Endocrinology
- Breast Cancer Research
Background:
- Neoadjuvant chemotherapy shows lower response rates in hormone receptor-positive (HR+) breast cancer compared to HR-.
- Preoperative endocrine therapy is a viable alternative, with aromatase inhibitors (AIs) demonstrating greater efficacy than tamoxifen for HR+ breast cancer.
Purpose of the Study:
- To evaluate the efficacy of neoadjuvant letrozole compared to tamoxifen in postmenopausal women with HR+ locally advanced breast cancer.
- To assess treatment response rates and surgical outcomes in patients receiving either letrozole or tamoxifen.
Main Methods:
- A large, multinational, double-blind trial (P024) involving postmenopausal women with HR+ breast cancer ineligible for breast-conserving surgery.
- Comparison of overall response rate (ORR) and rates of breast-conserving surgery between letrozole and tamoxifen treatment arms.
- Biomarker analyses including HER2 status, estrogen receptor (ER) positivity, and Ki67 expression.
Main Results:
- Letrozole achieved a significantly higher ORR (55%) compared to tamoxifen (36%) (P<0.001).
- More patients treated with letrozole underwent breast-conserving surgery (45% vs. 35%, P=0.022).
- Letrozole demonstrated superior efficacy in HER2+ and HER2- subgroups, reduced tumor proliferation (Ki67), and downregulated estrogen-regulated genes.
Conclusions:
- Neoadjuvant letrozole is a safe and effective treatment for postmenopausal women with HR+ locally advanced breast cancer.
- Letrozole offers superior clinical efficacy compared to tamoxifen, leading to improved response rates and surgical outcomes.
- The efficacy of letrozole is consistent across different ER and HER2 expression levels.
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...